Research and Consulting Services

Equifax

Ecofi Company Average Stock Price Target Cut to $223.32, Consensus Rating Remains Buy

Equifax Shares Hit 52-Week Low

Mitsubishi UFJ Reduces Stake in Equifax

Eufinancial CFO John W. Gamble Jr Sells Company Stocks

EAF CEO Mark Begor Exercised Options and Sold 37,791 Shares

Accuray Signs Fourth Amendment to Credit Agreement, Increases Unsecured Revolving Credit Facility to $2 Billion

EkoPhi Collaborates with Ataeva to Launch Financial Product Suite

Eikon's stock price falls, Morgan Stanley cuts target price

Citigroup Analyst Maintains Buy Rating On Equifax With A Price Target Of $238

Equifax Announces Q3 2025 Earnings and Raises Full-Year Guidance

Epsilon Reports 14% Revenue Growth in Q1 2026 with Adjusted EPS of $1.86

Equifax released FY2026 Q1 earnings on April 21 Pre-Market EST, actual revenue USD 1.649 B (forecast USD 1.618 B), actual EPS USD 1.42 (forecast USD 1.3095)

EY Q1 Revenue Beats Estimates

Jefferies Downgrades EFX Target Price to $220

ZWJ Investment Counsel Inc. reduced holdings in Equifax

EFX Launches Employment Number® Record Indicator

Equifax to Release FY2026 Q1 Earnings on April 21 Pre-Market EST, Forecast Revenue USD 1.617 B, EPS USD 1.3127

Barclays assigns Equifax a hold rating with a target price of $215

Equifax Reports US Consumer Debt Rises to $18.19 Trillion in February 2026

Epsilon Releases Shareholder Letter Highlighting Focus Strategy and Financial Achievements

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Ordinary dividend (cash)

Ex Date: 2026.05.22 (EST), Cash dividend 0.56 USD

Equifax Inc. (EFX) shares fell 2.07% to $160.83 on Tuesday, underperforming compared to competitors. The stock closed 42.77% below its 52-week high of $281.02. The S&P 500 Index and Dow Jones Industrial Average also declined by 0.67% and 0.65%, respectively. Trading volume was 1.5 million, below the 50-day average of 1.7 million.

MarketWatch Automated

S&P 500

Dow Jones Industrial Average

S&P Global

Moodys

Fortinet

Factset Research

Equifax Inc. Stock Underperforms Tuesday When Compared To Competitors

Equifax Inc. (EFX) shares rose 3.70% to $164.23 on a mixed trading day, outperforming competitors like S&P Global Inc. and Moody's Corp. The stock has gained for two consecutive days but remains 41.56% below its 52-week high of $281.03. Trading volume was 1.3 million, below the 50-day average of 1.7 million.

Equifax Inc. Stock Outperforms Competitors On Strong Trading Day

Equifax, Inc.'s average stock price target has been reduced from $224.45 to $223.32, suggesting a potential upside of 41% based on the May 15 closing price. The consensus rating remains 'Buy' from 29 analysts, with 19 Buys and 10 Holds.

TradingView

Equifax, Inc. Stock 12‑Month Price Target Cut to $223.32, Implies 41% Upside

Canada Post Corp Registered Pension Plan increased its stake in Equifax, Inc. (NYSE: EFX) by 1,253.8% in Q4, owning 24,978 shares valued at $5.42 million. Other institutional investors also raised their positions. Analysts have set new price targets for Equifax, with a consensus rating of 'Moderate Buy' and an average target price of $228.06. Equifax reported Q1 earnings of $1.86 EPS, exceeding estimates, with revenue of $1.65 billion, up 14.3% year-over-year.

Market Beat

Fair Isaac

Citigroup

Barclays

ROYAL BANK OF CANADA

Bank of Montreal

Mizuho Financial Group, Inc.

Mizuho Financial

CITIGROUP INC 6.250 NON CUM SER II PFD WI

Equifax, Inc. $EFX Shares Bought by Canada Post Corp Registered Pension Plan

Moody's Corp. (MCO) shares fell 1.29% to $432.68 on Thursday, marking the second consecutive day of losses, despite a positive trading session for the overall market. The S&P 500 rose 0.77% and the Dow Jones increased by 0.75%. Moody's stock is currently 20.88% below its 52-week high of $546.88 reached on January 15. In comparison, competitors S&P Global, MSCI, and Equifax also experienced declines.

MSCI

Moody's Corp. Stock Underperforms Thursday When Compared To Competitors

Madison Asset Management LLC has reduced its stake in Equifax, Inc. (NYSE: EFX) by 50.5%, selling 33,419 shares during the fourth quarter, leaving them with 32,760 shares valued at $7.1 million. Other institutional investors have also adjusted their positions, with Massachusetts Financial Services increasing its holdings by 35.8%. Equifax's stock has seen a decline of 4.1%, currently priced at $159.99, with a market cap of $19.05 billion. The company recently reported earnings of $1.86 per share, exceeding expectations, and announced a quarterly dividend of $0.56 per share.

JPMorgan Chase

Goldman Sachs

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

GS Hldg R

Madison Asset Management LLC Sells 33,419 Shares of Equifax, Inc. $EFX

Moody's Corp. (MCO) shares fell 2.97% to $438.32 on a mixed trading day, while the S&P 500 rose 0.58% and the Dow Jones fell 0.14%. The stock is 19.85% below its 52-week high of $546.88. Compared to competitors, Moody's outperformed S&P Global, MSCI, and Equifax, which saw declines of 4.15%, 1.75%, and 4.09%, respectively. Trading volume was 1.0 million, below the 50-day average of 1.2 million.

Moody's Corp. Stock Outperforms Competitors Despite Losses On The Day

Equifax (NYSE:EFX) shares hit a new 52-week low at $161.64, closing at $164.06. Analysts have downgraded price targets, with Barclays lowering it to $215 and UBS to $220. Despite this, 13 analysts rate it a Buy. The company reported Q1 earnings of $1.86 EPS, exceeding estimates, with a revenue increase of 14.3% year-over-year. Equifax announced a quarterly dividend of $0.56 per share, with a yield of 1.4%. Insider sales have occurred, with executives reducing their stakes. Hedge funds are adjusting their positions in the stock.

UBS Group AG

Cullen Frost Bankers

Equifax (NYSE:EFX) Sets New 1-Year Low  - Time to Sell?

Equifax shareholders reaffirmed the board and elected ten directors at the May 7, 2026 annual meeting. They ratified Ernst & Young as the independent auditor for fiscal 2026 and approved an advisory executive compensation program. A proposal to lower the ownership threshold for calling a special meeting to 25% was accepted, while a more aggressive 10% threshold was rejected. The current analyst rating for Equifax (EFX) stock is a Hold with a $200 price target, reflecting solid fundamentals but concerns over technical setup and balance-sheet risks.

Tip Ranks

Equifax Shareholders Reaffirm Board, Adjust Special Meeting Rules

Equifax Inc. (EFX) shares fell 4.56% to $167.82 on Monday, breaking a three-day winning streak, despite a positive trading day for the stock market. The S&P 500 and Dow Jones both rose 0.19%. Equifax's stock is currently 40.28% below its 52-week high of $281.03. In comparison, competitors S&P Global Inc. and Fortinet Inc. saw slight gains, while Moody's Corp. experienced a minor decline. Trading volume was below the 50-day average.

Equifax Inc. Stock Underperforms Monday When Compared To Competitors

Equifax(EFX.US)